Cargando…

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder

Background: The evaluation of treatment response to antidepressant therapy commonly depends on neuropsychologic assessments, as there are currently no suitable biomarkers. Previous research has identified a panel of increased proteins in patients with major depressive disorder (MDD), including antit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ruize, Shi, Yachen, Li, Xianrui, Zhu, Jianli, Zhang, Hongxing, Li, Kun, Wang, Bi, Zhang, Haisan, Yang, Yongfeng, Gao, Lijuan, Zhao, Yang, Zhang, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580946/ https://www.ncbi.nlm.nih.gov/pubmed/34777034 http://dx.doi.org/10.3389/fpsyt.2021.678384

Ejemplares similares

Altered Functional Connectivity Between the Cerebellum and the Cortico-Striato-Thalamo-Cortical Circuit in Obsessive-Compulsive Disorder
por: Zhang, Haisan, et al.
Publicado: (2019)

CACNA1C Gene rs11832738 Polymorphism Influences Depression Severity by Modulating Spontaneous Activity in the Right Middle Frontal Gyrus in Patients With Major Depressive Disorder
por: Liu, Xiaoyun, et al.
Publicado: (2020)

Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder
por: Shi, Yachen, et al.
Publicado: (2021)

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder
por: Liu, Xiaoyun, et al.
Publicado: (2020)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
por: Zhao, Lei, et al.
Publicado: (2022)

The Altered Somatic Brain Network in State Anxiety
por: Li, Xianrui, et al.
Publicado: (2019)

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
por: Lin, Eugene, et al.
Publicado: (2018)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

COMT Val158Met Polymorphism Influences the Cerebral Blood Flow Changes Related to Psychomotor Retardation in Major Depressive Disorder
por: Yin, Yingying, et al.
Publicado: (2022)

Insula network connectivity mediates the association between childhood maltreatment and depressive symptoms in major depressive disorder patients
por: He, Cancan, et al.
Publicado: (2022)

Effectiveness of yoga for major depressive disorder: A systematic review and meta-analysis
por: Wu, Yufei, et al.
Publicado: (2023)

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care
por: Salazar-Fraile, José, et al.
Publicado: (2018)

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
por: Xin, Juncai, et al.
Publicado: (2020)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
por: Wang, Qiang, et al.
Publicado: (2022)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
por: Safer, Daniel J., et al.
Publicado: (2019)

Alterations of core structural network connectome associated with suicidal ideation in major depressive disorder patients
por: Liu, Xinyi, et al.
Publicado: (2021)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

Antidepressant effect r TMS during pregnancy in a case of Major Depression Resistant to Pharmacological Treatment
por: Isabel, Martínez-Gras, et al.
Publicado: (2021)

Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
por: Shi, Yachen, et al.
Publicado: (2021)

Anatomical Connectivity-Based Strategy for Targeting Transcranial Magnetic Stimulation as Antidepressant Therapy
por: Tao, Qi, et al.
Publicado: (2020)

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Kennedy, Kevin P.
Publicado: (2022)

Trends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
por: Yu, Zhenwei, et al.
Publicado: (2020)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Is There a Role of Autophagy in Depression and Antidepressant Action?
por: Gassen, Nils C., et al.
Publicado: (2019)

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Henssler, Jonathan, et al.
Publicado: (2023)

Abnormalities in Electroencephalographic Microstates Among Adolescents With First Episode Major Depressive Disorder
por: He, Yuqiong, et al.
Publicado: (2021)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
por: Zhang, Ting, et al.
Publicado: (2022)

Aberrant Dynamic Functional Network Connectivity and Graph Properties in Major Depressive Disorder
por: Zhi, Dongmei, et al.
Publicado: (2018)

Exploration of Major Cognitive Deficits in Medication-Free Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2019)

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study
por: Agorastos, Agorastos, et al.
Publicado: (2020)

Incorporating multi-stage diagnosis status to mine associations between genetic risk variants and the multi-modality phenotype network in major depressive disorder
por: Zhang, Li, et al.
Publicado: (2023)

Prescribing behavior of antidepressants for depressive disorders: A systematic review
por: Lam, Mary K., et al.
Publicado: (2022)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
por: Liu, Jin, et al.
Publicado: (2021)

Comprehensive analysis of endoplasmic reticulum stress and immune infiltration in major depressive disorder
por: Zhang, Jing, et al.
Publicado: (2022)

National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
por: Luo, Yan, et al.
Publicado: (2020)

Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression
por: Yang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l58888h72dht9lltmpm4u3f3sg